North American CDMO Industry to 2030 – Players Include Aenova Group, Baxter BioPharma Solutions and Charles River Laboratories Among Others – ResearchAndMarkets.com

North American CDMO Industry to 2030 – Players Include Aenova Group, Baxter BioPharma Solutions and Charles River Laboratories Among Others – ResearchAndMarkets.com




North American CDMO Industry to 2030 – Players Include Aenova Group, Baxter BioPharma Solutions and Charles River Laboratories Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic Application, End User, and Country” report has been added to ResearchAndMarkets.com’s offering.

The North American pharmaceutical CDMO market is expected to grow by 6.0% annually in the forecast period and reach $101.1 billion by 2030 driven by increasing demand for biological therapies and specialty medicines, rising demand for cost control in drug development, and rising healthcare expenditures.

Highlighted with 37 tables and 50 figures, this report is based on comprehensive research of the entire North America pharmaceutical CDMO market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies of the period 2015-2019 and provides a forecast from 2020 till 2030 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America pharmaceutical CDMO market in every aspect of the classification from perspectives of Category, Service Type, Therapeutic Application, End User, and Country.

Key Players:

Company Profiles of CMO:

  • Aenova Group
  • Baxter BioPharma Solutions
  • Boehringer Ingelheim
  • Catalent Inc.
  • Famar S.A.
  • Hospira, Inc.
  • Jubilant Life Sciences Ltd.
  • Lonza Group
  • Patheon Inc.
  • Pfizer CentreSource
  • Recipharm AB
  • Vetter Pharma International GmbH

Company Profiles of CRO:

  • Charles River Laboratories
  • CMIC Co. Ltd
  • Covance Inc.
  • Hangzhou Tigermed Consulting Co Ltd
  • ICON Plc
  • IQVIA Holdings Inc.
  • LSK North America Pharma Service Co Ltd
  • Novotech Pty Ltd
  • PAREXEL International Corporation
  • Pharmaceutical Product Development LLC (PPD)
  • PRA Health Sciences Inc.
  • Quanticate Ltd
  • Samsung Bioepis Co. Ltd
  • SGS SA (SGS Life Sciences)
  • Syneos Health Inc.
  • WuXi AppTec Inc.

Key Topics Covered:

1 Introduction

1.1 Industry Definition and Research Scope

1.1.1 Industry Definition

1.1.2 Research Scope

1.2 Research Methodology

1.2.1 Overview of Market Research Methodology

1.2.2 Market Assumption

1.2.3 Secondary Data

1.2.4 Primary Data

1.2.5 Data Filtration and Model Design

1.2.6 Market Size/Share Estimation

1.2.7 Research Limitations

1.3 Executive Summary

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.1.1 Impact of COVID-19 on World Economy

2.1.2 Impact of COVID-19 on the Market

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter’s Fiver Forces Analysis

3 Segmentation of North America Market by Category

3.1 Market Overview by Category

3.2 Pharmaceutical Industry

3.3 Biopharmaceutical Industry

4 Segmentation of North America Market by Service Type

4.1 Market Overview by Service Type

4.2 Pharmaceutical Contract Manufacturing Organization (CMO)

4.2.1 Active Pharmaceutical Ingredients (API)

4.2.2 Finished Dosage Formulations (FDF)

4.2.3 Secondary Packaging

4.3 Pharmaceutical Contract Research Organization (CRO)

4.3.1 CRO for Pre-clinical Development

4.3.2 CRO for Phase I Trials

4.3.3 CRO for Phase II Trials

4.3.4 CRO for Phase III Trials

4.3.5 CRO for Phase IV Trials

4.3.6 Laboratory Services

4.3.7 Consulting Services

4.3.8 Data Management Services

5 Segmentation of North America Market by Therapeutic Application

5.1 Market Overview by Therapeutic Application

5.2 Infectious Diseases

5.3 Oncology

5.4 Metabolic Disorders

5.5 Cardiovascular Disorders

5.6 Central Nervous System

5.7 Pulmonary Disorders

5.8 Gastrointestinal Disorders

5.9 Other Therapeutic Applications

6 Segmentation of North America Market by End User

6.1 Market Overview by End User

6.2 Pharmaceutical & Biopharmaceutical Companies

6.3 Medical Device Companies

6.4 Academic Institutes

7 North America Market 2019-2030 by Country

7.1 Overview of North America Market

7.2 U.S.

7.3 Canada

7.4 Mexico

8 Competitive Landscape

8.1 Overview of Key Vendors

8.2 New Product Launch, Partnership, Investment, and M&A

8.3 Company Profiles

8.3.1 Company Profiles of CMO

8.3.2 Company Profiles of CRO

9 Investing in North America Market: Risk Assessment and Management

9.1 Risk Evaluation of North America Market

9.2 Critical Success Factors (CSFs)

For more information about this report visit https://www.researchandmarkets.com/r/w63f0e

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900